Clinical Trials Directory

Trials / Terminated

TerminatedNCT01145703

Vitamin D Supplementation and Metabolism in Vitamin D Deficient Elderly

Effects of Vitamin D Supplementation With and With Out Exercise on Metabolic and Physical Consequences of Vitamin D Deficiency in the Elderly

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Baltimore VA Medical Center · Federal
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the effects of Vitamin D supplementation on the reasons (mechanisms) underlying the development of type 2 diabetes, metabolic syndrome (high blood pressure, cholesterol, diabetes, body weight/obesity), muscle weakness and wasting (sarcopenia), and impaired physical function (poor balance and walking) associated with vitamin D deficiency and osteopenia/osteoporosis (bone loss). The investigators obtain vitamin D through our diet and sunlight, and its conversion to active vitamins in the liver and kidneys promotes the intestinal absorption of calcium and regulation of bone growth. Therefore, vitamin D deficiency has been known for years to lead to weakened bones (osteopenia and osteoporosis). However, more recently, studies show vitamin D deficiency is associated with a number of other diseases, including type 2 diabetes, muscle weakness, frailty, and the metabolic syndrome. It has also been associated with cognitive impairment. Diabetes affects multiple organ systems including the heart, kidneys, musculoskeletal and nervous system. The possibility that vitamin D deficiency is linked to the development of type 2 diabetes, metabolic syndrome, muscle weakness and wasting (sarcopenia) and osteopenia/osteoporosis, and that vitamin D supplementation decreases the risk for these diseases, provides a relatively easy/accessible and inexpensive model of preventive therapy to decrease the incidence of these diseases. In addition, it is likely that genetic (inherited) factors play a role, but the relationship of these genes to these metabolic abnormalities have not been elucidated. Understanding the role of Vitamin D in health will allow us to translate these findings into therapy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTRDA Vitamin D3 only800 IU of Vitamin D3 daily for 6 months
DIETARY_SUPPLEMENTVitamin D2/3 Repletion onlyVitamin D repletion with 50,000 IU of Vitamin D2/3 up to 3 x week(until levels are \>75 nmol/l; 6-12wks) followed by 6 months maintenance supplementation with 2000 IU Vitamin D3 and up to 1000mg Calcium daily
OTHERVitamin D2/3 Repletion + AEXVitamin D repletion with 50,000 IU of Vitamin D2/3 up to 3 x week(until levels are \>75 nmol/l; 6-12wks) followed by 6 months maintenance supplementation with 2000 IU Vitamin D3 and up to 1000mg Calcium daily plus aerobic exercise training
OTHERVitamin D2/3 Repletion + RTVitamin D repletion with 50,000 IU of Vitamin D2/3 up to 3 x week(until levels are \>75 nmol/l; 6-12wks) followed by 6 months maintenance supplementation with 2000 IU Vitamin D3 and up to 1000mg Calcium daily plus resistance training

Timeline

Start date
2010-05-01
Primary completion
2013-02-01
Completion
2013-02-01
First posted
2010-06-17
Last updated
2014-09-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01145703. Inclusion in this directory is not an endorsement.